• Mutation; VGNC; VGNC:54284; CCND3; Simple; p.Arg358fs (c.1071_1075delCAGAG); Zygosity=Heterozygous (PubMed=31175136).
  
• Mutation; VGNC; VGNC:47719; TP53; Simple; p.Ala127Val (c.380C>T); Zygosity=Heterozygous (PubMed=31175136).
  
• Mutation; VGNC; VGNC:47719; TP53; Simple; p.Arg257His (c.770G>A); Zygosity=Heterozygous (PubMed=31175136).
  

PubMed=20153049; DOI=10.1016/j.leukres.2010.01.021
Barbara C. Rutgen, Sabine E. Hammer, Wilhelm Gerner, Maria Christian, Abigail Guija de Arespacochaga, Michael Willmann, Miriam Kleiter, Ilse Schwendenwein, Armin Saalmuller;
Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma.
Leuk. Res. 34:932-938(2010)

PubMed=22761949; DOI=10.1371/journal.pone.0040078; PMCID=PMC3386195
Barbara C. Rutgen, Saskia Willenbrock, Nicola Reimann-Berg, Ingrid Walter, Andrea Fuchs-Baumgartinger, Siegfried Wagner, Boris Kovacic, Sabine E. Hammer, Ilse Schwendenwein, Ingo Nolte, Armin Saalmuller, Hugo Murua Escobar;
Authentication of primordial characteristics of the CLBL-1 cell line prove the integrity of a canine B-cell lymphoma in a murine in vivo model.
PLoS ONE 7:e40078.1-e40078.13(2012)

PubMed=23365669; DOI=10.1371/journal.pone.0054464; PMCID=PMC3554772
James W. Wells, Christopher H. Evans, Milcah C. Scott, Barbara C. Rutgen, Timothy D. O'Brien, Jaime F. Modiano, Goran Cvetkovic, Slobodan Tepic;
Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.
PLoS ONE 8:e54464.1-e54464.9(2013)

PubMed=27257868; DOI=10.1371/journal.pone.0156689; PMCID=PMC4892608
Junko Maeda, Coral Eva Froning, Colleen A. Brents, Barbara J. Rose, Douglas H. Thamm, Takamitsu A. Kato;
Intrinsic radiosensitivity and cellular characterization of 27 canine cancer cell lines.
PLoS ONE 11:e0156689.1-e0156689.18(2016)

PubMed=27639374; DOI=10.1186/s12917-016-0836-z; PMCID=PMC5027081
Sarah C. Roode, Daniel Miller Rotroff, Kristy L. Richards, Peter F. Moore, Alison Anne Motsinger-Reif, Yasuhiko Okamura, Takuya Mizuno, Hajime Tsujimoto, Steven E. Suter, Matthew Breen;
Comprehensive genomic characterization of five canine lymphoid tumor cell lines.
BMC Vet. Res. 12:207.1-207.16(2016)

PubMed=27197945; DOI=10.1111/vco.12192; PMCID=PMC5656225
Jared S. Fowles, Deanna D. Dailey, Daniel L. Gustafson, Douglas H. Thamm, Dawn L. Duval;
The Flint Animal Cancer Center (FACC) canine tumour cell line panel: a resource for veterinary drug discovery, comparative oncology and translational medicine.
Vet. Comp. Oncol. 15:481-492(2017)

PubMed=29674676; DOI=10.1038/s41598-018-23207-7; PMCID=PMC5908872
Leila Taher, Julia Beck, Wen Liu, Catrin Roolf, Jan T. Soller, Barbara C. Rutgen, Sabine E. Hammer, Murali Chodisetti, Sina Sender, Katharina Anna Sterenczak, Georg Fuellen ...Show all 16 authors... , Christian Junghanss, Bertram Brenig, Ingo Nolte, Ekkehard Schutz, Hugo Murua Escobar; Show fewer authors
Comparative high-resolution transcriptome sequencing of lymphoma cell lines and de novo lymphomas reveals cell-line-specific pathway dysregulation.
Sci. Rep. 8:6279-6279(2018)

PubMed=31175136; DOI=10.1158/1535-7163.MCT-18-1346; PMCID=PMC6679748
Sunetra Das, Rupa Idate, Kathryn E. Cronise, Daniel L. Gustafson, Dawn L. Duval;
Identifying candidate druggable targets in canine cancer cell lines using whole-exome sequencing.
Mol. Cancer Ther. 18:1460-1471(2019)

PubMed=32651429; DOI=10.1038/s41598-020-68470-9; PMCID=PMC7351721
Takuya Mizuno, Yukinari Kato, Mika Kato Kaneko, Yusuke Sakai, Toshinori Shiga, Masahiro Kato, Toshihiro Tsukui, Hirofumi Takemoto, Akio Tokimasa, Kenji Baba, Yuki Nemoto ...Show all 13 authors... , Osamu Sakai, Masaya Igase; Show fewer authors
Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment.
Sci. Rep. 10:11476.1-11476.12(2020)